First Header Logo Second Header Logo

Connection

Karen Haas to Cell Proliferation

This is a "connection" page, showing publications Karen Haas has written about Cell Proliferation.
Connection Strength

0.457
  1. Dyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.
    View in: PubMed
    Score: 0.154
  2. Haas KM, Johnson KL, Phipps JP, Do C. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol. 2018 03 01; 200(5):1671-1681.
    View in: PubMed
    Score: 0.133
  3. McKay JT, Haro MA, Daly CA, Yammani RD, Pang B, Swords WE, Haas KM. PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism. J Immunol. 2017 09 15; 199(6):2020-2029.
    View in: PubMed
    Score: 0.128
  4. Crump KE, Juneau DG, Poole LB, Haas KM, Grayson JM. The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur J Immunol. 2012 Aug; 42(8):2152-64.
    View in: PubMed
    Score: 0.023
  5. Smith SH, Haas KM, Poe JC, Yanaba K, Ward CD, Migone TS, Tedder TF. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol. 2010 Aug; 22(8):681-91.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.